Literature DB >> 10624722

Psychopathology, mother-child interaction, and infant development: substance-abusing mothers and their offspring.

L Beckwith1, J Howard, M Espinosa, R Tyler.   

Abstract

The course of severe depressive symptoms from pregnancy to 6 months postpartum, as well as the occurrence of severe paranoid symptoms prenatally, were examined by the Millon Clinical Multiaxial Inventory I and the Beck Depression Inventory, in 78 women who were heavy, chronic cocaine users and who retained custody of their children after birth. Six months postpartum, the quality of caregiving was observed and assessed in the home, and the children were assessed on the Bayley MDI Index in the laboratory. Mothers who were depressed and paranoid prenatally, regardless of whether the depression continued to 6 months postpartum, were less sensitive in caregiving than women without severe symptoms of paranoia or depression during pregnancy or those who reported only depression that lifted by 6 months postpartum. Mothers who were depressed prenatally and continued to be depressed by 6 months postpartum, regardless of the presence or absence of paranoia, had infants who earned lower Bayley MDI scores than the offspring of women without severe psychological symptoms or women whose depression had lifted. Severe depressive symptoms during pregnancy, if they did not continue to 6 months postpartum, did not appear to adversely influence either caregiving or infant functioning.

Entities:  

Mesh:

Year:  1999        PMID: 10624722     DOI: 10.1017/s095457949900228x

Source DB:  PubMed          Journal:  Dev Psychopathol        ISSN: 0954-5794


  17 in total

Review 1.  Prenatal and postpartum maternal psychological distress and infant development: a systematic review.

Authors:  Dawn Kingston; Suzanne Tough; Heather Whitfield
Journal:  Child Psychiatry Hum Dev       Date:  2012-10

2.  Neurobehavioral and Developmental Traiectories Associated with Level of Prenatal Cocaine Exposure.

Authors:  Claudia A Chiriboga; Louise Kuhn; Gail A Wasserman
Journal:  J Neurol Psychol       Date:  2014-11

3.  How early bonding, depression, illicit drug use, and perceived support work together to influence drug-dependent mothers' caregiving.

Authors:  Nancy E Suchman; Thomas J McMahon; Arietta Slade; Suniya S Luthar
Journal:  Am J Orthopsychiatry       Date:  2005-07

4.  Parenting Efficacy and Support in Mothers With Dual Disorders in a Substance Abuse Treatment Program.

Authors:  Suzanne Brown; Laurel M Hicks; Elizabeth M Tracy
Journal:  J Dual Diagn       Date:  2016-10-14

5.  Effects of prenatal cocaine/polydrug use on maternal-infant feeding interactions during the first year of life.

Authors:  Sonia Minnes; Lynn T Singer; Robert Arendt; Sudtida Satayathum
Journal:  J Dev Behav Pediatr       Date:  2005-06       Impact factor: 2.225

6.  Longitudinal effects of prenatal cocaine use on mother-child interactions at ages 3 and 5 years.

Authors:  Elana Mansoor; Connie E Morrow; Veronica H Accornero; Lihua Xue; Arnise L Johnson; James C Anthony; Emmalee S Bandstra
Journal:  J Dev Behav Pediatr       Date:  2012-01       Impact factor: 2.225

7.  The Mediating Role of Parenting Stress in Methadone-Maintained Mothers' Parenting.

Authors:  Nancy E Suchman; Suniya S Luthar
Journal:  Parent Sci Pract       Date:  2001-10

8.  Maternal cocaine use: estimated effects on mother-child play interactions in the preschool period.

Authors:  Arnise L Johnson; Connie E Morrow; Veronica H Accornero; Lihua Xue; James C Anthony; Emmalee S Bandstra
Journal:  J Dev Behav Pediatr       Date:  2002-08       Impact factor: 2.225

9.  EMOTIONALLY AVOIDANT LANGUAGE IN THE PARENTING INTERVIEWS OF SUBSTANCE-DEPENDENT MOTHERS: ASSOCIATIONS WITH REFLECTIVE FUNCTIONING, RECENT SUBSTANCE USE, AND PARENTING BEHAVIOR.

Authors:  Jessica L Borelli; Jessica L West; Cindy Decoste; Nancy E Suchman
Journal:  Infant Ment Health J       Date:  2012-05-22

10.  Profiles of Reactivity in Cocaine-Exposed Children.

Authors:  Pamela Schuetze; Danielle S Molnar; Rina D Eiden
Journal:  J Appl Dev Psychol       Date:  2012-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.